Segmed’s offerings support the advancement of cardiovascular research by providing high-quality, regulatory-grade real-world imaging datasets (RWiD) and multimodal longitudinal datasets. Our datasets offer the precision and insights essential for pharmaceutical companies to develop groundbreaking treatments and interventions in cardiology.br br Contact us to learn how our datasets can help improve the precision and early detection of cardiovascular conditions.